casalonga logo

French Supreme Court - Biogaran v. the MSD/Organon companies


Decision date

2025-08-31

Nature

Patent

Country

France

Jurisdiction

French Supreme Court

Parties

Biogaran v. the MSD/Organon companies



Representation of Biogaran against the MSD/Organon companies in PI proceedings relating to the French SPC protecting the combination of Ezetimibe and Simvastatin, resulting in the final invalidation of the SPC and the final dismissal of MSD/Organon’s application for a preliminary injunction following its withdrawal before the French Supreme Court.

Biogaran was represented by Marianne Gabriel attorney-at-law at the Paris Bar.